Is Now The Time to Take a Bite Out of dentalcorp Stock?

Photo of author
Written By Dean McHugh

dentalcorp Holdings Ltd. (OTCPK, TSX:DNTL) owns dental practices across Canada and pursues a roll-up strategy to consolidate the fragmented industry. With 550 dental practices in its network, dentalcorp holds a 3.7% market share in Canada, making it the market leader.

Despite this, the company’s growth rate has slowed, burdened by significant debt and a Net debt to EBITDA ratio of 4.3x.

Recent Underperformance

Credits: DepositPhotos

dentalcorp’s growth has decelerated, with the company currently struggling with debt. Since November 2022, the company has not fulfilled its commitment to unlock shareholder value, as evidenced by the poor share price performance. Over the last three years, the company’s shares have been halved.

Despite attempts to leverage its market position, the company’s growth ambitions remain questionable, and concerns about its overall leverage persist.

In a letter to dentalcorp’s management, Buckley Capital Management, a U.S.-based investment firm owning 1.4% of the company, urged dentalcorp to undertake another strategic review process.

Buckley noted that the previous strategic review likely failed due to the March 2023 banking crisis and frozen credit markets, which made it challenging to consummate a deal. They believe that with the improved financing environment, dentalcorp is now in a stronger position to consider a transaction.

EBITDA Margin Contraction

At the RBC Global Healthcare Conference, dentalcorp emphasized potential margin expansion through significant investments in corporate infrastructure. Management noted the potential for around 20bps of margin expansion in 2024, growing to 25-30bps in subsequent years.

However, EBITDA margins have actually declined, dropping from 19.4% in December 2021 to 18.5% as of the last quarter. Despite positive adjusted EBITDA, the company has never earned a profit in terms of net income.

Financial Performance and Strategy

dentalcorp’s financial performance has shown significant challenges. Despite generating positive adjusted EBITDA, the company has consistently posted net losses. The adjustments from net income to adjusted EBITDA reveal that a substantial portion of the difference comes from adding back interest expenses and depreciation and amortization. For a highly leveraged business like dentalcorp, these interest expenses represent real costs, impacting the company’s true earnings and cash flow.

Valuation and Comparison

Currently, dentalcorp is trading at approximately 12.8x EV/EBITDA. For comparison, WELL Health Technologies and Neighbourly Pharmacy operate with similar dynamics and end markets. Neighbourly was acquired at 11x 2024E IFRS EBITDA, with a 3.6% FCF yield on trailing twelve-month free cash flow.

Assuming a similar acquisition multiple for dentalcorp, a takeout price of $15.00 per share could be estimated. However, on an EBITDA basis, dentalcorp trading above the acquired price implies downside due to higher free cash flow generation at Neighbourly.

Challenges and Future Outlook

dentalcorp faces significant challenges, particularly regarding its high leverage in a high-interest rate environment. The company’s leverage ratio of 4.3x poses substantial risk, despite an interest rate of 6.3%. Furthermore, same practice revenue growth has fluctuated, averaging around 3.4% post-IPO, despite CPI averaging 5.0% over the same period.

Although volumes are growing across the network, management needs to focus on deleveraging the balance sheet to improve investor sentiment and attract financial buyers.

Proceed With Caution

Credits: DepositPhotos

dentalcorp Holdings Ltd. continues to face significant challenges in delivering sustainable growth. Despite holding a leading market position in the dental industry, the company’s high leverage, fluctuating margins, and inconsistent financial performance raise concerns.

The current strategy has not yielded the expected results, and unless there is a substantial shift towards deleveraging and improving operational efficiency, significant share price appreciation seems unlikely. For now, dentalcorp remains a high-risk investment, and potential investors should be cautious.

DISCLAIMER

You should read and understand this disclaimer in its entirety before joining or viewing the website or email/blog list of SmallCapStocks.com (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help.

The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at www.sec.gov; the Financial Industry Regulatory Authority (the "FINRA") at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.gov/consumer/cyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.

The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.

By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link: www.SmallCapStocks.com/Disclaimer and www.SmallCapStocks.com/Privacy-Policy

By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.